Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

A woman's excessive hair growth was caused by a rare benign tumor in her adrenal gland, which was successfully removed.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Free testosterone is the most common hormone marker in PCOS, and age affects DHEAS levels.

Certain hormone levels can help diagnose P450 oxidoreductase deficiency.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

DHEA improved brain function and behavior in old monkeys and had additional health benefits.

A postmenopausal woman's virilization was caused by a rare ovarian tumor that was hard to detect but was successfully treated with surgery.